Chondroitin Sulfate Sodium
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09301 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 2 | primitive portal vein thrombosis | KG + DL |
| 3 | idiopathic copper-associated cirrhosis | KG + DL |
| 4 | hepatopulmonary syndrome | KG + DL |
| 5 | hepatoportal sclerosis | KG + DL |
| 6 | hepatic porphyria | KG + DL |
| 7 | primary release disorder of platelets | KG + DL |
| 8 | Glanzmann thrombasthenia | KG + DL |
| 9 | pseudo-von Willebrand disease | KG + DL |
| 10 | glycogen storage disease due to hepatic glycogen synthase deficiency | KG + DL |
| 11 | Ledderhose disease | KG + DL |
| 12 | congenital prothrombin deficiency | KG + DL |
| 13 | congenital hypotrichosis milia | KG + DL |
| 14 | hypotrichosis simplex of the scalp | KG + DL |
| 15 | adenosine deaminase deficiency | KG + DL |
| 16 | infantile digital fibromatosis | KG + DL |
| 17 | Scott syndrome | KG + DL |
| 18 | palmar fibromatosis | KG + DL |
| 19 | obsolete hyperuricemia (disease) | KG + DL |
| 20 | diffuse alopecia areata | KG + DL |
| 21 | severe combined immunodeficiency due to LCK deficiency | KG + DL |
| 22 | bleeding diathesis due to a collagen receptor defect | KG + DL |
| 23 | hemorrhagic disorder due to a constitutional thrombocytopenia | KG + DL |
| 24 | cholangiocarcinoma, susceptibility to | KG + DL |
| 25 | lymphopenic hypergammaglobulinemia, antibody deficiency, autoimmune hemolytic anemia, and glomerulonephritis | KG + DL |
| 26 | non-specific granulomatous orchitis | KG + DL |
| 27 | epidural abscess | KG + DL |
| 28 | hemoglobin C-beta-thalassemia syndrome | KG + DL |
| 29 | ocular tuberculosis | KG + DL |
| 30 | reticular dysgenesis | KG + DL |
| 31 | hilar cholangiocarcinoma | KG + DL |
| 32 | ergotism | KG + DL |
| 33 | congenital cystic eye multiple ocular and intracranial anomalies | KG + DL |
| 34 | Kozlowski Warren Fisher syndrome | KG + DL |
| 35 | sunburn | KG + DL |
| 36 | inherited thrombophilia | KG + DL |
| 37 | paramedian facial cleft | KG + DL |
| 38 | obsolete pathologic fracture | KG + DL |
| 39 | giant neutrophil leukocytes | KG + DL |
| 40 | penile fibromatosis | KG + DL |
| 41 | craniofacial dystonia | KG + DL |
| 42 | alpha granule disease | KG + DL |
| 43 | guttate psoriasis | KG + DL |
| 44 | mixed receptive-expressive language disorder | KG + DL |
| 45 | aphasia | KG + DL |
| 46 | muscular disease | KG + DL |
| 47 | lymphatic malformation | KG + DL |
| 48 | distal monosomy 7p | KG + DL |
| 49 | anuria | KG + DL |
| 50 | glycoprotein storage disease | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.